Browsing Category
Healthcare Industry News
2470 posts
REIT U-turn: Why Four Corners Property Trust (NYSE: FCPT) just bought a $3.3m dental clinic — And what it signals for investors
Find out how Four Corners Property Trust’s $3.3M Heartland Dental deal signals a new direction in REIT diversification and stable yield strategy.
Tharimmune (NASDAQ: THAR) resale filing unlocks 0.326m shares — Is dilution risk back on the table?
Tharimmune’s 0.326 M-share resale filing raises liquidity and dilution questions for THAR investors. Learn what it means for stock sentiment and outlook.
Is GeoVax’s 11.9m share move a warning sign for investors—Or the setup for a surprise comeback?
Find out how GeoVax Labs’ 11.9 M-share sale is testing investor faith in its vaccine pipeline and what it means for the small-cap biotech’s future.
Tivic Health Systems (NASDAQ: TIVC) share sale filing: What 1.58m registered shares mean for investors
Find out why Tivic Health’s 1.58 million-share resale filing could pressure TIVC stock and what investors should watch next for recovery signs.
Hims & Hers Health plunges 11% after CEO Andrew Dudum offloads $11m in stock
Shares of Hims & Hers Health fell 11% after CEO Andrew Dudum disclosed a multimillion-dollar stock sale. Find out what’s worrying investors next.
Microsoft brings Dragon Copilot AI to nurses, promising smarter workflows and better care outcomes
Discover how Microsoft is extending its Dragon Copilot AI to nurses and partners—see how this expansion could transform patient care and efficiency.
GRAIL stock surges 14% after $110m Samsung deal to expand Galleri test in Asia
GRAIL stock jumps 14% after Samsung's $110M investment and Asia commercialization deal for its Galleri cancer test. Learn how investors are reacting.
Merit Medical (NASDAQ: MMSI) bets on C2 CryoBalloon technology—can this $22m deal redefine its GI strategy?
Merit Medical (MMSI) will acquire the C2 CryoBalloon from Pentax for $22M to expand its GI therapy portfolio. Explore deal impact, investor sentiment, and growth outlook.
Why did Becton Dickinson appoint Vitor Roque as interim CFO, and what’s next for BDX stock?
Becton Dickinson (NYSE: BDX) names Vitor Roque as interim CFO as Christopher DelOrefice exits. Find out what this means for BDX’s strategy and investor sentiment.
What CVS’s full acquisition of Rite Aid pharmacies means for patients and competitors
Find out how CVS Health’s full acquisition of Rite Aid’s pharmacy assets is reshaping U.S. retail healthcare and what it means for patients and competitors.